| [1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| [2] |
Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? [J]. Int J Epidemiol, 1980, 9(3): 227-231.
|
| [3] |
Yin L, Ordonez-Mena JM, Chen T, et al. Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis [J]. Prev Med, 2013, 57(6): 753-764.
|
| [4] |
Grant WB. Ecological studies of the UVB-vitamin D-cancer hypothesis [J]. Anticancer Res, 2012, 32(1): 223-236.
|
| [5] |
Ma Y, Zhang P, Wang F, et al. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies [J]. J Clin Oncol, 2011, 29(28): 3775-3782.
|
| [6] |
Holick MF. Vitamin D deficiency [J]. N Engl J Med, 2007, 357(3): 266-281.
|
| [7] |
Chiang KC, Chen TC. The anti-cancer actions of vitamin D [J]. Anticancer Agents Med Chem, 2013, 13(1): 126-139.
|
| [8] |
Campbell MJ, Adorini L. The vitamin D receptor as a therapeutic target [J]. Expert Opin Ther Targets, 2006, 10(5): 735-748.
|
| [9] |
Ogunkolade BW, Boucher BJ, Fairclough PD, et al. Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer [J]. Lancet, 2002, 359(9320): 1831-1832.
|
| [10] |
Ditsch N, Toth B, Mayr D, et al. The association between vitamin D receptor expression and prolonged overall survival in breast cancer [J]. J Histochem Cytochem, 2012, 60(2): 121-129.
|
| [11] |
Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial [J]. Am J Clin Nutr, 2007, 85(6): 1586-1591.
|
| [12] |
Maalmi H, Ordonez-Mena JM, Schottker B, et al. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies [J]. Eur J Cancer, 2014, 50(8): 1510-1521.
|
| [13] |
Li M, Chen P, Li J, et al. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis [J]. J Clin Endocrinol Metab, 2014, 99(7): 2327-2336.
|
| [14] |
Fuchs MA, Yuan C, Sato K, et al. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance) [J]. Ann Oncol, 2017, 28(6): 1359-1367.
|
| [15] |
Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer [J]. N Engl J Med, 2006, 354(7): 684-696.
|
| [16] |
Avenell A, MacLennan GS, Jenkinson DJ, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial) [J]. J Clin Endocrinol Metab, 2012, 97(2): 614-622.
|
| [17] |
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial [J]. BMJ, 2003, 326(7387): 469.
|
| [18] |
Ng K, Scott JB, Drake BF, et al. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial [J]. Am J Clin Nutr, 2014, 99(3): 587-598.
|
| [19] |
Ross AC,Taylor CL,Yaktine AL, et al. Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium: The National Academies Collection: Reports funded by National Institutes of Health. In: Dietary Reference Intakes for Calcium and Vitamin D [M]. edn. Washington (DC): National Academies Press (US) National Academy of Sciences, 2011.
|
| [20] |
Chen G. Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer [J]. Chin J Gastrointest Surg, 2017, 20(1): 28-33.
|
| [21] |
Pradhan AD, Manson JE. Update on the Vitamin D and OmegA-3 trial (VITAL) [J]. J Steroid Biochem Mol Biol, 2016, 155(Pt B): 252-256.
|
| [22] |
Neale RE, Armstrong BK, Baxter C, et al. The D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancer [J]. Contemp Clin Trials, 2016, 48: 83-90.
|
| [23] |
Leslie A, Carey FA, Pratt NR, et al. The colorectal adenoma-carcinoma sequence [J]. Br J Surg, 2002, 89(7): 845-860.
|
| [24] |
Hummel DM, Thiem U, Hobaus J, et al. Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis [J]. J Steroid Biochem Mol Biol, 2013, 136: 284-288.
|
| [25] |
Fichera A, Little N, Dougherty U, et al. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model [J]. J Surg Res, 2007, 142(2): 239-245.
|
| [26] |
Wei MY, Garland CF, Gorham ED, et al. Vitamin D and prevention of colorectal adenoma: a meta-analysis [J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(11): 2958-2969.
|
| [27] |
Ahmad II, Trikudanathan G, Feinn R, et al. Low Serum Vitamin D: A Surrogate Marker for Advanced Colon Adenoma? [J]. J Clin Gastroenterol, 2016, 50(8): 644-648.
|
| [28] |
Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians′ Network[J]. N Engl J Med, 2000, 342(16): 1156-1162.
|
| [29] |
Alberts DS, Martinez ME, Hess LM, et al. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence[J]. J Natl Cancer Inst, 2005, 97(11): 846-853.
|
| [30] |
Baron JA, Barry EL, Mott LA, et al. A trial of calcium and vitamin D for the prevention of colorectal adenomas [J]. N Engl J Med, 2015, 373(16): 1519-1530.
|
| [31] |
Barry EL, Peacock JL, Rees JR, et al. Vitamin D receptor genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial [J]. JAMA Oncol, 2017, 3(5): 628-635.
|
| [32] |
DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014 [J]. CA Cancer J Clin, 2014, 64(4): 252-271.
|
| [33] |
Mantell DJ, Owens PE, Bundred NJ, et al. 1 alpha, 25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo [J]. Circ Res, 2000, 87(3): 214-220.
|
| [34] |
Elez E, Argiles G, Tabernero J. First-line treatment of metastatic colorectal cancer: interpreting FIRE-3, PEAK, and CALGB/SWOG 80405 [J]. Curr Treat Options Oncol, 2015, 16(11): 52.
|
| [35] |
Ng K, Sargent DJ, Goldberg RM, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741 [J]. J Clin Oncol, 2011, 29(12): 1599-1606.
|